Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_assertion type Assertion NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_head.
- NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_provenance.
- NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_assertion evidence source_evidence_literature NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_provenance.
- NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_assertion SIO_000772 21833654 NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_provenance.
- NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_assertion wasDerivedFrom befree-20140225 NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_provenance.
- NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_assertion wasGeneratedBy ECO_0000203 NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_provenance.